JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors ; volume:43 ; number:1 ; day:1 ; month:3 ; year:2024 ; pages:1-20 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (1.3.2024), 1-20, 12.2024
- Urheber
-
Pennel, Kathryn A. F.
Hatthakarnkul, Phimmada
Wood, Colin S.
Lian, Guang-Yu
Al-Badran, Sara S. F.
Quinn, Jean A.
Legrini, Assya
Inthagard, Jitwadee
Alexander, Peter G.
Wyk, Hester van
Kurniawan, Ahmad
Hashmi, Umar
Gillespie, Michael A.
Mills, Megan
Ammar, Aula
Hay, Jennifer
Andersen, Ditte
Nixon, Colin
Rebus, Selma
Chang, David K.
Kelly, Caroline
Harkin, Andrea
Graham, Janet
Church, David
Tomlinson, Ian
Saunders, Mark
Iveson, Tim
Lannagan, Tamsin R. M.
Jackstadt, Rene
Maka, Noori
Horgan, Paul G.
Roxburgh, Campbell S. D.
Sansom, Owen J.
McMillan, Donald C.
Steele, Colin W.
Jamieson, Nigel B.
Park, James H.
Roseweir, Antonia K.
Edwards, Joanne
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-024-02958-4
- URN
-
urn:nbn:de:101:1-2405052100085.218475598001
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pennel, Kathryn A. F.
- Hatthakarnkul, Phimmada
- Wood, Colin S.
- Lian, Guang-Yu
- Al-Badran, Sara S. F.
- Quinn, Jean A.
- Legrini, Assya
- Inthagard, Jitwadee
- Alexander, Peter G.
- Wyk, Hester van
- Kurniawan, Ahmad
- Hashmi, Umar
- Gillespie, Michael A.
- Mills, Megan
- Ammar, Aula
- Hay, Jennifer
- Andersen, Ditte
- Nixon, Colin
- Rebus, Selma
- Chang, David K.
- Kelly, Caroline
- Harkin, Andrea
- Graham, Janet
- Church, David
- Tomlinson, Ian
- Saunders, Mark
- Iveson, Tim
- Lannagan, Tamsin R. M.
- Jackstadt, Rene
- Maka, Noori
- Horgan, Paul G.
- Roxburgh, Campbell S. D.
- Sansom, Owen J.
- McMillan, Donald C.
- Steele, Colin W.
- Jamieson, Nigel B.
- Park, James H.
- Roseweir, Antonia K.
- Edwards, Joanne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Adulte Neurogenese: Die Rolle des JAK/STAT3-Wegs
In vitro biomaterial priming of human mesenchymal stromal/stem cells : implication of the Src/JAK/STAT3 pathway in vasculogenic mimicry
MANTOWN REPRESENTS "iBO"
JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process
Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway
IFITM3 promotes glioblastoma stem cell-mediated angiogenesis via regulating JAK/STAT3/bFGF signaling pathway
Die Inhibition des gp130/JAK/STAT3-Signalweges mittels SC144 als innovatives Target beim duktalen Pankreasadenokarzinom
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Adulte Neurogenese: Die Rolle des JAK/STAT3-Wegs
In vitro biomaterial priming of human mesenchymal stromal/stem cells : implication of the Src/JAK/STAT3 pathway in vasculogenic mimicry
MANTOWN REPRESENTS "iBO"
JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process
Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway
IFITM3 promotes glioblastoma stem cell-mediated angiogenesis via regulating JAK/STAT3/bFGF signaling pathway
Die Inhibition des gp130/JAK/STAT3-Signalweges mittels SC144 als innovatives Target beim duktalen Pankreasadenokarzinom
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Adulte Neurogenese: Die Rolle des JAK/STAT3-Wegs
In vitro biomaterial priming of human mesenchymal stromal/stem cells : implication of the Src/JAK/STAT3 pathway in vasculogenic mimicry
MANTOWN REPRESENTS "iBO"
JAK/STAT3 regulated global gene expression dynamics during late-stage reprogramming process
Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway
IFITM3 promotes glioblastoma stem cell-mediated angiogenesis via regulating JAK/STAT3/bFGF signaling pathway
Die Inhibition des gp130/JAK/STAT3-Signalweges mittels SC144 als innovatives Target beim duktalen Pankreasadenokarzinom